| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 16 | 2023 | 1453 | 1.310 |
Why?
|
| Poloxamer | 6 | 2012 | 13 | 1.130 |
Why?
|
| Nephrectomy | 5 | 2012 | 49 | 1.010 |
Why?
|
| Radiology, Interventional | 2 | 2023 | 27 | 0.940 |
Why?
|
| Robotics | 2 | 2023 | 48 | 0.930 |
Why?
|
| Radiology Department, Hospital | 2 | 2020 | 24 | 0.850 |
Why?
|
| Lung Neoplasms | 7 | 2021 | 546 | 0.840 |
Why?
|
| Biliary Tract Surgical Procedures | 2 | 2018 | 11 | 0.800 |
Why?
|
| Hepatectomy | 2 | 2018 | 59 | 0.720 |
Why?
|
| Penile Induration | 1 | 2020 | 4 | 0.700 |
Why?
|
| Embolization, Therapeutic | 7 | 2013 | 307 | 0.690 |
Why?
|
| Iohexol | 4 | 2012 | 18 | 0.690 |
Why?
|
| Hemostasis, Surgical | 4 | 2012 | 16 | 0.680 |
Why?
|
| Robotic Surgical Procedures | 1 | 2021 | 95 | 0.660 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2018 | 26 | 0.640 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2021 | 2022 | 0.600 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2018 | 166 | 0.600 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 275 | 0.560 |
Why?
|
| Thoracic Surgery, Video-Assisted | 2 | 2015 | 51 | 0.480 |
Why?
|
| Biliary Tract Diseases | 2 | 2018 | 18 | 0.480 |
Why?
|
| Pneumothorax, Artificial | 1 | 2014 | 1 | 0.470 |
Why?
|
| Fiducial Markers | 1 | 2014 | 4 | 0.470 |
Why?
|
| Contrast Media | 6 | 2011 | 405 | 0.460 |
Why?
|
| Chest Tubes | 1 | 2014 | 14 | 0.460 |
Why?
|
| Renal Artery | 3 | 2011 | 29 | 0.460 |
Why?
|
| Coronary Sinus | 1 | 2013 | 5 | 0.450 |
Why?
|
| Vascular Fistula | 1 | 2013 | 7 | 0.450 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2014 | 54 | 0.450 |
Why?
|
| Pneumonectomy | 1 | 2014 | 82 | 0.440 |
Why?
|
| Heart Defects, Congenital | 1 | 2013 | 81 | 0.430 |
Why?
|
| Postoperative Complications | 1 | 2018 | 1123 | 0.400 |
Why?
|
| Needles | 2 | 2023 | 63 | 0.400 |
Why?
|
| Surgical Instruments | 1 | 2011 | 40 | 0.390 |
Why?
|
| Blood Loss, Surgical | 4 | 2012 | 55 | 0.380 |
Why?
|
| Cholangiography | 2 | 2018 | 42 | 0.360 |
Why?
|
| Hemostatics | 1 | 2010 | 26 | 0.340 |
Why?
|
| External Fixators | 2 | 2021 | 6 | 0.340 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2010 | 85 | 0.330 |
Why?
|
| Fracture Fixation | 2 | 2021 | 14 | 0.330 |
Why?
|
| Kidney | 1 | 2011 | 391 | 0.330 |
Why?
|
| Cholangiopancreatography, Magnetic Resonance | 1 | 2008 | 9 | 0.320 |
Why?
|
| Humans | 36 | 2023 | 59008 | 0.320 |
Why?
|
| Varicocele | 1 | 2008 | 6 | 0.310 |
Why?
|
| Sperm Motility | 1 | 2008 | 46 | 0.310 |
Why?
|
| Infertility, Male | 1 | 2008 | 58 | 0.300 |
Why?
|
| Male | 26 | 2021 | 27369 | 0.280 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 2 | 2018 | 50 | 0.280 |
Why?
|
| Middle Aged | 20 | 2020 | 16184 | 0.280 |
Why?
|
| Early Detection of Cancer | 4 | 2021 | 260 | 0.260 |
Why?
|
| Swine | 6 | 2012 | 337 | 0.260 |
Why?
|
| Myocardial Infarction | 2 | 2003 | 855 | 0.250 |
Why?
|
| Phantoms, Imaging | 3 | 2021 | 210 | 0.240 |
Why?
|
| Gadolinium DTPA | 2 | 2002 | 85 | 0.230 |
Why?
|
| Mesenteric Veins | 2 | 2013 | 11 | 0.220 |
Why?
|
| Manganese Compounds | 1 | 2003 | 7 | 0.210 |
Why?
|
| Arteriovenous Fistula | 2 | 2013 | 39 | 0.210 |
Why?
|
| Oxygen | 4 | 2012 | 307 | 0.210 |
Why?
|
| Feasibility Studies | 6 | 2018 | 518 | 0.210 |
Why?
|
| Organometallic Compounds | 1 | 2003 | 64 | 0.200 |
Why?
|
| Biopsy | 1 | 2023 | 373 | 0.200 |
Why?
|
| Carbon Dioxide | 3 | 2010 | 74 | 0.200 |
Why?
|
| Adult | 13 | 2018 | 15659 | 0.190 |
Why?
|
| Retrospective Studies | 6 | 2020 | 5949 | 0.180 |
Why?
|
| Workflow | 1 | 2020 | 58 | 0.180 |
Why?
|
| Predictive Value of Tests | 3 | 2014 | 1022 | 0.180 |
Why?
|
| Appointments and Schedules | 1 | 2020 | 53 | 0.180 |
Why?
|
| Penis | 1 | 2020 | 23 | 0.170 |
Why?
|
| Efficiency, Organizational | 1 | 2020 | 95 | 0.170 |
Why?
|
| Sensitivity and Specificity | 8 | 2014 | 1091 | 0.160 |
Why?
|
| Aged | 15 | 2018 | 13259 | 0.160 |
Why?
|
| Jejunostomy | 1 | 2018 | 7 | 0.160 |
Why?
|
| Phlebography | 4 | 2013 | 43 | 0.160 |
Why?
|
| Pilot Projects | 2 | 2020 | 912 | 0.160 |
Why?
|
| Computer Simulation | 1 | 2020 | 448 | 0.150 |
Why?
|
| Fracture Healing | 1 | 2017 | 25 | 0.150 |
Why?
|
| Female | 21 | 2018 | 30662 | 0.150 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2011 | 180 | 0.140 |
Why?
|
| Diagnosis-Related Groups | 1 | 2017 | 86 | 0.140 |
Why?
|
| Endovascular Procedures | 2 | 2013 | 559 | 0.140 |
Why?
|
| Stents | 2 | 2011 | 432 | 0.140 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 101 | 0.140 |
Why?
|
| Fractures, Bone | 1 | 2017 | 137 | 0.130 |
Why?
|
| Treatment Outcome | 5 | 2018 | 5129 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2021 | 3078 | 0.130 |
Why?
|
| Ureteroscopes | 1 | 2015 | 1 | 0.130 |
Why?
|
| Lithotripsy, Laser | 1 | 2015 | 2 | 0.130 |
Why?
|
| Choledocholithiasis | 1 | 2015 | 5 | 0.130 |
Why?
|
| Patient Compliance | 1 | 2017 | 370 | 0.120 |
Why?
|
| Angiography, Digital Subtraction | 5 | 2013 | 133 | 0.120 |
Why?
|
| Mass Screening | 3 | 2017 | 637 | 0.120 |
Why?
|
| Reproducibility of Results | 4 | 2014 | 1540 | 0.120 |
Why?
|
| Liver | 3 | 2011 | 780 | 0.120 |
Why?
|
| Inpatients | 1 | 2017 | 290 | 0.120 |
Why?
|
| Colitis, Ischemic | 1 | 2013 | 1 | 0.110 |
Why?
|
| Mesenteric Artery, Inferior | 1 | 2013 | 4 | 0.110 |
Why?
|
| Hypercapnia | 2 | 2010 | 8 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2015 | 163 | 0.110 |
Why?
|
| Hyperoxia | 2 | 2010 | 15 | 0.110 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 98 | 0.110 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2013 | 91 | 0.110 |
Why?
|
| Radiology | 1 | 2017 | 230 | 0.110 |
Why?
|
| Heart Atria | 1 | 2013 | 137 | 0.110 |
Why?
|
| Mesenteric Artery, Superior | 1 | 2012 | 14 | 0.110 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 321 | 0.100 |
Why?
|
| Statistics, Nonparametric | 3 | 2008 | 207 | 0.100 |
Why?
|
| Smoking | 2 | 2014 | 829 | 0.100 |
Why?
|
| Renal Circulation | 1 | 2012 | 10 | 0.100 |
Why?
|
| Oximetry | 1 | 2012 | 47 | 0.100 |
Why?
|
| Oxides | 2 | 2002 | 33 | 0.100 |
Why?
|
| Liver Circulation | 1 | 2011 | 10 | 0.100 |
Why?
|
| Molecular Imaging | 1 | 2012 | 47 | 0.100 |
Why?
|
| Animals | 8 | 2012 | 19531 | 0.100 |
Why?
|
| Hepatic Artery | 1 | 2011 | 21 | 0.100 |
Why?
|
| Colectomy | 1 | 2012 | 98 | 0.100 |
Why?
|
| Portal Vein | 1 | 2011 | 36 | 0.100 |
Why?
|
| Glioblastoma | 2 | 2010 | 150 | 0.100 |
Why?
|
| Iron | 2 | 2002 | 144 | 0.100 |
Why?
|
| Random Allocation | 1 | 2011 | 198 | 0.090 |
Why?
|
| Patient Selection | 1 | 2013 | 443 | 0.090 |
Why?
|
| Brain Neoplasms | 2 | 2010 | 305 | 0.090 |
Why?
|
| Respiration | 1 | 2010 | 85 | 0.090 |
Why?
|
| Cerebral Angiography | 1 | 2011 | 278 | 0.080 |
Why?
|
| Brain Mapping | 1 | 2010 | 230 | 0.080 |
Why?
|
| Laparoscopy | 2 | 2011 | 385 | 0.080 |
Why?
|
| Brain | 4 | 2010 | 1483 | 0.080 |
Why?
|
| Aorta, Thoracic | 1 | 2009 | 77 | 0.080 |
Why?
|
| Sclerosing Solutions | 1 | 2008 | 5 | 0.080 |
Why?
|
| Temperature | 1 | 2010 | 300 | 0.080 |
Why?
|
| Sperm Count | 1 | 2008 | 18 | 0.080 |
Why?
|
| Propranolol | 1 | 2008 | 22 | 0.080 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2008 | 19 | 0.080 |
Why?
|
| Tetrazoles | 1 | 2008 | 20 | 0.080 |
Why?
|
| Biphenyl Compounds | 1 | 2008 | 29 | 0.080 |
Why?
|
| Hypertension, Portal | 1 | 2008 | 15 | 0.080 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2008 | 26 | 0.080 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2009 | 98 | 0.080 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 541 | 0.080 |
Why?
|
| Radiography, Interventional | 1 | 2008 | 67 | 0.070 |
Why?
|
| Intracranial Aneurysm | 1 | 2011 | 333 | 0.070 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 149 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 162 | 0.070 |
Why?
|
| Antihypertensive Agents | 1 | 2008 | 172 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2008 | 157 | 0.070 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2003 | 141 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2013 | 794 | 0.060 |
Why?
|
| Logistic Models | 1 | 2008 | 1246 | 0.060 |
Why?
|
| Hippocampus | 2 | 2003 | 238 | 0.060 |
Why?
|
| Radiology Information Systems | 2 | 2014 | 28 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2005 | 249 | 0.050 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2003 | 3 | 0.050 |
Why?
|
| Time Factors | 4 | 2012 | 3552 | 0.050 |
Why?
|
| Thalamus | 1 | 2003 | 62 | 0.050 |
Why?
|
| Intracranial Embolism | 1 | 2003 | 39 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2021 | 1896 | 0.050 |
Why?
|
| Neoplasms | 1 | 2012 | 1222 | 0.050 |
Why?
|
| Aspartic Acid | 1 | 2002 | 29 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2018 | 5058 | 0.050 |
Why?
|
| Abdomen | 1 | 2002 | 89 | 0.050 |
Why?
|
| Analysis of Variance | 1 | 2003 | 576 | 0.050 |
Why?
|
| Aortic Valve | 1 | 2003 | 163 | 0.050 |
Why?
|
| Cardiac Catheterization | 1 | 2003 | 239 | 0.050 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2003 | 569 | 0.050 |
Why?
|
| Tissue Survival | 1 | 2001 | 3 | 0.050 |
Why?
|
| Magnets | 1 | 2021 | 3 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2002 | 290 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2010 | 635 | 0.050 |
Why?
|
| Pregnancy | 1 | 2008 | 2334 | 0.050 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2012 | 168 | 0.040 |
Why?
|
| Cadaver | 1 | 2021 | 102 | 0.040 |
Why?
|
| Aortic Valve Stenosis | 1 | 2003 | 167 | 0.040 |
Why?
|
| Radiologists | 1 | 2021 | 74 | 0.040 |
Why?
|
| Rats | 1 | 2003 | 1904 | 0.040 |
Why?
|
| Risk Factors | 3 | 2017 | 4983 | 0.040 |
Why?
|
| Surgical Stomas | 1 | 2018 | 8 | 0.040 |
Why?
|
| Punctures | 1 | 2018 | 53 | 0.040 |
Why?
|
| Catheterization | 1 | 2018 | 109 | 0.040 |
Why?
|
| Anastomosis, Surgical | 1 | 2018 | 97 | 0.040 |
Why?
|
| United States | 3 | 2017 | 7458 | 0.040 |
Why?
|
| Adolescent | 1 | 2008 | 5888 | 0.040 |
Why?
|
| Injury Severity Score | 1 | 2017 | 103 | 0.040 |
Why?
|
| Neuroradiography | 1 | 2017 | 10 | 0.040 |
Why?
|
| Artifacts | 2 | 2011 | 126 | 0.030 |
Why?
|
| Trauma Centers | 1 | 2017 | 120 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 313 | 0.030 |
Why?
|
| Lung | 1 | 2021 | 818 | 0.030 |
Why?
|
| Alzheimer Disease | 1 | 2002 | 547 | 0.030 |
Why?
|
| Hamartoma | 1 | 2015 | 6 | 0.030 |
Why?
|
| Mediastinoscopy | 1 | 2015 | 6 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2003 | 2051 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 312 | 0.030 |
Why?
|
| Granuloma | 1 | 2015 | 38 | 0.030 |
Why?
|
| Thoracotomy | 1 | 2015 | 45 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 349 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 837 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 254 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 261 | 0.030 |
Why?
|
| Length of Stay | 1 | 2017 | 761 | 0.030 |
Why?
|
| Prognosis | 1 | 2017 | 1563 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2013 | 91 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 2012 | 56 | 0.030 |
Why?
|
| Ferrosoferric Oxide | 2 | 2002 | 18 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2012 | 109 | 0.030 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 244 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2013 | 121 | 0.030 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 328 | 0.030 |
Why?
|
| Dextrans | 2 | 2002 | 44 | 0.030 |
Why?
|
| Magnetite Nanoparticles | 2 | 2002 | 28 | 0.020 |
Why?
|
| Organ Sparing Treatments | 1 | 2011 | 14 | 0.020 |
Why?
|
| Cattle | 1 | 2011 | 307 | 0.020 |
Why?
|
| Image Enhancement | 1 | 2012 | 190 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1084 | 0.020 |
Why?
|
| Incidence | 1 | 2014 | 1231 | 0.020 |
Why?
|
| Models, Animal | 1 | 2011 | 219 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2012 | 553 | 0.020 |
Why?
|
| Echo-Planar Imaging | 1 | 2010 | 32 | 0.020 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2010 | 51 | 0.020 |
Why?
|
| Meningioma | 1 | 2010 | 57 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 446 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 701 | 0.020 |
Why?
|
| Portal Pressure | 1 | 2008 | 1 | 0.020 |
Why?
|
| Chest Pain | 1 | 2009 | 85 | 0.020 |
Why?
|
| Natriuresis | 1 | 2008 | 5 | 0.020 |
Why?
|
| Renin | 1 | 2008 | 9 | 0.020 |
Why?
|
| Massachusetts | 1 | 2014 | 2082 | 0.020 |
Why?
|
| Liver Function Tests | 1 | 2008 | 36 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2013 | 641 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 242 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2008 | 683 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2009 | 521 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2008 | 806 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2005 | 168 | 0.010 |
Why?
|
| Putamen | 1 | 2003 | 19 | 0.010 |
Why?
|
| Caudate Nucleus | 1 | 2003 | 25 | 0.010 |
Why?
|
| Pressure | 1 | 2003 | 74 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2005 | 265 | 0.010 |
Why?
|
| Kidney Cortex | 1 | 2002 | 10 | 0.010 |
Why?
|
| Choline | 1 | 2002 | 21 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 2002 | 24 | 0.010 |
Why?
|
| Diffusion | 1 | 2002 | 84 | 0.010 |
Why?
|
| Creatine | 1 | 2002 | 26 | 0.010 |
Why?
|
| Rabbits | 1 | 2002 | 330 | 0.010 |
Why?
|
| Observer Variation | 1 | 2002 | 201 | 0.010 |
Why?
|
| ROC Curve | 1 | 2002 | 259 | 0.010 |
Why?
|
| Spleen | 1 | 2002 | 485 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 4294 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 894 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2003 | 2449 | 0.010 |
Why?
|